Javascript must be enabled to continue!
Vulvar mastocytosis: atypical location
View through CrossRef
Mastocytosis represents a heterogeneous group of disorders characterized by excessive proliferation and accumulation of clonal (neoplastic) mast cells (MCs) in one or more organ systems. The differential diagnosis of mastocytosis is based on the evaluation of complaints, the presence of specific symptoms related to mast cell activation syndrome, and the assessment of symptom severity. In vulvar mastocytosis, there may be edema, hyperemia, and pain in the vulva associated with spontaneous or allergen-induced histamine release. Of importance is the detection of non-specific markers: blood tryptase and products of histamine metabolism in the urine, which may be increased either due to elevated levels of basophils, or because of their pathologic activation. The mandatory diagnostic method is biopsy and immunohistochemistry for CD117, CD25, CD2, CD30 markers, tryptase levels in a sample, and determination of specific, more pronounced basophil staining. In recent years, the detection of KIT D816V mutation by sensitive allele-specific quantitative PCR has been a reliable screening method. This clinical case demonstrates the relevance of the problem of mastocytosis and its differential diagnosis in medical practice, since this disease is quite rare and causes diagnostic difficulties.
Key words: mastocytosis, cutaneous mastocytosis, vulvar neoplasms, c-KIT
Title: Vulvar mastocytosis: atypical location
Description:
Mastocytosis represents a heterogeneous group of disorders characterized by excessive proliferation and accumulation of clonal (neoplastic) mast cells (MCs) in one or more organ systems.
The differential diagnosis of mastocytosis is based on the evaluation of complaints, the presence of specific symptoms related to mast cell activation syndrome, and the assessment of symptom severity.
In vulvar mastocytosis, there may be edema, hyperemia, and pain in the vulva associated with spontaneous or allergen-induced histamine release.
Of importance is the detection of non-specific markers: blood tryptase and products of histamine metabolism in the urine, which may be increased either due to elevated levels of basophils, or because of their pathologic activation.
The mandatory diagnostic method is biopsy and immunohistochemistry for CD117, CD25, CD2, CD30 markers, tryptase levels in a sample, and determination of specific, more pronounced basophil staining.
In recent years, the detection of KIT D816V mutation by sensitive allele-specific quantitative PCR has been a reliable screening method.
This clinical case demonstrates the relevance of the problem of mastocytosis and its differential diagnosis in medical practice, since this disease is quite rare and causes diagnostic difficulties.
Key words: mastocytosis, cutaneous mastocytosis, vulvar neoplasms, c-KIT.
Related Results
Epidemiology of mastocytosis: a population-based study (Sweden)
Epidemiology of mastocytosis: a population-based study (Sweden)
Background: Mastocytosis is a disease characterized by accumulation of aberrant mast cells and mediator-related symptoms and is divided into systemic mastocytosis (SM) and cutaneou...
Features of the treatment of cutaneous mastocytosis in children
Features of the treatment of cutaneous mastocytosis in children
Mastocytosis is a heterogeneous group of diseases with accumulation of clonal mast cells in tissues. Mastocytosis is characterized by complex pathogenesis, diverse clinical picture...
Review and Updates on Systemic Mastocytosis and Related Entities
Review and Updates on Systemic Mastocytosis and Related Entities
Mast cell disorders range from benign proliferations to systemic diseases that cause anaphylaxis and other diverse symptoms to mast cell neoplasms with varied clinical outcomes. Ma...
Vulvar Dystrophies: An Evaluation
Vulvar Dystrophies: An Evaluation
EDITORIAL COMMENT: This paper provides readers with a logical plan of treatment for patients presenting with pruritus, vulvitis or visible vulvar disease who are found on directed...
Safety and efficacy of lirentelimab in patients with refractory indolent systemic mastocytosis: a first-in-human clinical trial
Safety and efficacy of lirentelimab in patients with refractory indolent systemic mastocytosis: a first-in-human clinical trial
Abstract
Background
Indolent systemic mastocytosis (ISM) is characterized by excessive mast cell (MC) accumulation and MC-driven...
Vulvar malignancies: an interdisciplinary perspective
Vulvar malignancies: an interdisciplinary perspective
SummaryVulvar cancer represents the fourth most common gynecologic malignancy and is often encountered by the general Dermatologist or Gynecologist. Dermatooncologists and Gynecolo...
Diagnosis of Cutaneous Mastocytosis in an Adult Patient: A Case Report
Diagnosis of Cutaneous Mastocytosis in an Adult Patient: A Case Report
The cutaneous mastocytosis is characterized by infiltration and proliferation of mast cells in the skin with no evidence of extracutaneous involvement. The clinical findings most f...
Vulvar dermatofibrosarcoma protuberans, an unusual anatomical location
Vulvar dermatofibrosarcoma protuberans, an unusual anatomical location
Abstract
Vulvar dermatofibrosarcoma protuberans (DFSP) is a rare pathology. So far, only limited number of cases have been reported in literature. In the present cas...

